A Randomized, Controlled, Open-label Study to Assess the the Efficacy of Enteral Nutrition in Fill of the Treatment Blank Period of the Postoperative Maintain Remission Medication for Crohn's Disease (CD).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Azathioprine (Primary)
- Indications Crohn's disease
- Focus Biomarker; Therapeutic Use
- 16 Apr 2013 New trial record
- 04 Apr 2013 Biomarkers information updated